Actively Recruiting
Evaluating Tranexamic Acid Pharmacokinetics and Pharmacodynamics for Preventing Postpartum Hemorrhage in Pregnant Women Undergoing Cesarean or Vaginal Delivery
Led by Inova Health Care Services · Updated on 2026-10-16
120
Participants Needed
2
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the use of tranexamic acid TXA to prevent postpartum hemorrhage in pregnant women. This phase 2 trial focuses on pregnant women in their third trimester who are scheduled for cesarean or vaginal delivery, including those who are morbidly obese. The study aims to understand how TXA behaves in the body pharmacokinetics and pharmacodynamics depending on the dose and route of administration, helping to optimize its use during childbirth. The study includes different groups receiving 1 gram of TXA administered before delivery via three routes intravenous infusion over 10 minutes, intravenous push in less than 2 minutes, and intramuscular injection. A control group will not receive TXA. Blood and breast milk samples will be collected at multiple time points after dosing to measure drug levels and effects. The study plans to enroll a total of 223 participants across these groups to account for potential loss to follow-up. Participants will undergo plasma sampling at various times from drug administration up to 18 hours postpartum, with each blood draw about 7-9 mL. Breast milk samples will also be collected during maternal feedings. Researchers will monitor blood loss during surgery and safety parameters during hospital stay and up to 6 weeks postpartum. The study will last until April 2028, with detailed assessments to determine the optimal TXA dosing and administration method for preventing bleeding after childbirth.
CONDITIONS
Brief Title
Prevention of Postpartum Hemorrhage With Tranexamic Acid
Research Team
H
Homa K Ahmadzia, MD
J
Jaclyn Phillips
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here